Latest News on Stem Cell Research
I know everybody has been keenly following the Ocata clinical trial using human derived embryonic stem cells to treat both Stargardt’s Disease and Age Related Macular Degeneration. Ocata published a press release on 31 March. Here are the main points:
- The Phase I/II study has been successfully completed on 38 patients with both conditions. This phase was to look at safety and dosing of the stem cells and has been reported to have no major risks or adverse events.
- The Phase II part of the study has been given the go ahead and will also be conducted in England as well as the United States.
- The next phase will once again be looking at the safety and also the efficacy (ie if it improves vision) against a control group (used as a comparison for change). The effects of immuno-suppressant drug use will also be evaluated.
2/257 West St Carlton NSW 2218
0414 944 277